Purchase Order HHSN302201700281P

<p>The National Human Genome Research Institute awarded a purchase order to Life Technologies Corporation valued at $5,172.00 on August 2, 2017, for completion by September 1, 2017. Place of performance is North Bethesda, Maryland. The order is for firm fixed price commercial items, with no small business set-aside applied.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Life Technologies Corporation for $5,712.00 on August 18, 2017, with ultimate completion by September 15, 2017. Place of performance is Bethesda, Maryland. The order is priced firm fixed price with no set-aside designation. Specific deliverables or line items are not detailed in the source.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Life Technologies Corporation on July 19, 2018, for $3,038.08, with an ultimate completion date of September 9, 2019. Work is performed in North Bethesda, Maryland. The order is a firm fixed price acquisition for commercial laboratory supplies or reagents supporting genomic research infrastructure. No small business set-aside applies.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Life Technologies Corporation valued at $4,452.00 on September 15, 2017, for firm fixed price commercial items. Place of performance is Bethesda, Maryland. The order has an ultimate completion date of December 31, 2017. No set-aside was used.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Life Technologies Corporation valued at $18,816.00 on August 31, 2018, with ultimate completion on September 28, 2018. Place of performance is Bethesda, Maryland. The order is priced as firm fixed price with no set-aside used. The source does not specify the items or services procured.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Life Technologies Corporation valued at $18,551.24 on January 30, 2018, with an ultimate completion date of February 21, 2019. The order covers laboratory instrumentation, reagents, and consumables. Place of performance is Bethesda, Maryland. The contract carries firm fixed price and no small business set-aside designation.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Life Technologies Corporation valued at $11,980.00 on August 24, 2017, with completion by September 22, 2017. Performance occurs in Bethesda, Maryland. The order procures laboratory supplies and equipment on a firm fixed-price basis with no set-aside designation.</p>

The National Human Genome Research Institute awarded a purchase order to Life Technologies Corporation on August 10, 2019, for $22,278.60, with an ultimate completion date of October 31, 2019. Performance occurs in Bethesda, Maryland. The order is priced on a firm fixed price basis with no set-aside category. Life Technologies supplies laboratory instrumentation, reagents, and consumables to federal research and health agencies; the source does not specify the particular items or quantities...

<p>The National Human Genome Research Institute awarded a purchase order to Life Technologies Corporation for $14,772.60 on August 29, 2019, with performance completion by August 31, 2020. No set-aside applied. Place of performance is Bethesda, Maryland. The order calls for laboratory instrumentation, reagents, or consumables consistent with Life Technologies' federal product portfolio in genetic analysis and molecular biology. Pricing is firm fixed price on a commercial basis.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Life Technologies Corporation for $9,207 on July 28, 2017. Performance is located in North Bethesda, Maryland. The order carries firm fixed pricing with an ultimate completion date of August 27, 2017. No set-aside category applies.</p>